Q32 Bio (QTTB) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | -5.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.75% |
| Dec 31, 2025 | -3.16% |
| Sep 30, 2025 | -8.92% |
| Jun 30, 2025 | -12.30% |
| Mar 31, 2025 | -14.28% |
| Dec 31, 2024 | -15.27% |
| Sep 30, 2024 | -64.30% |
| Jun 30, 2024 | -64.39% |
| Mar 31, 2024 | -64.20% |
| Dec 31, 2023 | -63.62% |
| Jun 30, 2023 | -72.53% |
| Mar 31, 2023 | -70.78% |
| Dec 31, 2022 | -70.67% |
| Sep 30, 2022 | -67.55% |
| Jun 30, 2022 | -65.29% |
| Mar 31, 2022 | -63.54% |
| Dec 31, 2021 | -60.17% |
| Sep 30, 2021 | 16.38% |
| Jun 30, 2021 | 70.45% |
| Mar 31, 2021 | 111.37% |
| Dec 31, 2020 | 127.22% |